← Open Payments lookup

MICHELLE MILLMAN: Open Payments

NPI 1801263512 · FARMINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,697 in 83 payments from 18 companies in 2025. Trend: 2023 $1,416 · 2024 $1,652 · 2025 $1,697

Food & beverage: $1,697
CompanyPaymentsAmount
Novo Nordisk Inc13$319
AstraZeneca Pharmaceuticals LP13$259
GlaxoSmithKline, LLC.14$187
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$153
PFIZER INC.8$143
Otsuka America Pharmaceutical, Inc.1$125
ABBVIE INC.4$90
Amgen Inc.4$67
Abbott Laboratories3$67
Lilly USA, LLC4$59

Products named: Ozempic, REXULTI, TRELEGY ELLIPTA, CAPLYTA, AIRSUPRA, PREVNAR 20, BREZTRI, VRAYLAR.

Industry payments across MI — which companies pay providers there.